• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 ACCUCATH 20 GX2.25; CATHETER,INTRAVASCULAR,THERAPEUTIC,SHORT-TERM LESS THAN 30 DAYS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 ACCUCATH 20 GX2.25; CATHETER,INTRAVASCULAR,THERAPEUTIC,SHORT-TERM LESS THAN 30 DAYS Back to Search Results
Model Number AC0202250
Device Problems Defective Component (2292); Material Protrusion/Extrusion (2979)
Patient Problems No Consequences Or Impact To Patient (2199); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/30/2020
Event Type  malfunction  
Manufacturer Narrative
The device has not been returned to the manufacturer for evaluation.A lot history review (lhr) review is not possible, as no manufacturing lot number has been provided by the complainant.
 
Event Description
It was reported the device exhibits a wire protruding from the needle flash notch.No other information was provided.
 
Event Description
It was reported the device exhibits a wire protruding from the needle flash notch.No other information was provided.
 
Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The following were reviewed as part of this investigation: patient severity, trend analysis, applicable previous investigation(s), sample (if available), and applicable fmea documents.Based on a review of this information, the following was concluded: the complaint of the wire protruding from the flash port of the needle was confirmed.The product returned for evaluation was one accucath peripheral iv catheter assembly.Usage residues were observed throughout the sample.The safety button was depressed and the needle was partially withdrawn into the housing.The needle protruded from the flash notch, preventing complete needle withdrawal.The guidewire was intact.Microscopic inspection of the wire confirmed it to be intact.Inspection of the needle bevel was unremarkable.The misdirection of the needle prevented the safety mechanism from fully activating.The needle misdirection appeared to have been caused by wire advancement against resistance, such as into tissue and the use residues suggested that attempted advancement occurred during attempted device placement.H3 other text: evaluation findings are in section h.11.
 
Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The following were reviewed as part of this investigation: patient severity, trend analysis, applicable previous investigation(s), sample (if available), and applicable fmea documents.Based on a review of this information, the following was concluded: the complaint of the wire protruding from the flash port of the needle was confirmed.The product returned for evaluation was one accucath peripheral iv catheter assembly.Usage residues were observed throughout the sample.The safety button was depressed and the needle was partially withdrawn into the housing.The needle protruded from the flash notch, preventing complete needle withdrawal.The guidewire was intact.Microscopic inspection of the wire confirmed it to be intact.Inspection of the needle bevel was unremarkable.The misdirection of the needle prevented the safety mechanism from fully activating.The needle misdirection appeared to have been caused by wire advancement against resistance, such as into tissue and the use residues suggested that attempted advancement occurred during attempted device placement.
 
Event Description
It was reported the device exhibits a wire protruding from the needle flash notch.No other information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCUCATH 20 GX2.25
Type of Device
CATHETER,INTRAVASCULAR,THERAPEUTIC,SHORT-TERM LESS THAN 30 DAYS
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
MDR Report Key11061887
MDR Text Key223799330
Report Number3006260740-2020-21050
Device Sequence Number1
Product Code FOZ
UDI-Device Identifier00801741110948
UDI-Public(01)00801741110948
Combination Product (y/n)N
PMA/PMN Number
K153298
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,other
Type of Report Initial,Followup,Followup
Report Date 01/26/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberAC0202250
Device Catalogue NumberAC0202250
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/05/2020
Initial Date Manufacturer Received 12/01/2020
Initial Date FDA Received12/23/2020
Supplement Dates Manufacturer Received01/26/2021
01/26/2021
Supplement Dates FDA Received02/26/2021
03/09/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age57 YR
Patient Weight94
-
-